Summary:
- New research indicates that postmenopausal women who utilize estrogen-only hormone therapy may experience a reduced risk of developing Alzheimer’s disease.
- The study highlights the critical importance of the timing of hormonal intervention, suggesting that the "window of opportunity" during the early stages of menopause is a key factor in neuroprotection.
- These findings provide significant insights into the biological interplay between sex hormones and cognitive health, potentially informing future clinical guidelines for hormone replacement therapy.